An Australian-first study demonstrating the effectiveness of a new immunization against respiratory syncytial virus (RSV) for ...

The bivalent respiratory syncytial virus prefusion F vaccine is highly effective and well tolerated against RSV-associated ...

RSV jab slashes hospital admissions by 30% for older people, data suggests - NHS England started rolling out the vaccine for ...

The United Kingdom’s Health Security Agency (HSA) yesterday published it first annual report on infectious disease trends, ...

Pfizer shares are trading lower Wednesday after a Wall Street Journal report revealed that U.S. prosecutors are investigating ...

Novavax reached a settlement with Gavi, the Vaccine Alliance, after t | International vaccine partnership Gavi has ...

Population-based analyses of new vaccination programmes provide robust real-world evidence for post-licensure vaccine ...

Abrysvo, which is now the first maternal RSV vaccine to be prequalified by the organisation, aims to prevent RSV-associated ...

EARLY data from the respiratory syncytial virus (RSV) vaccination programme shows it is reducing hospital admissions for older people. The UK Health Security Agency (UKHSA) analysis indicates 30 per ...

Fresno County health officials have confirmed the first pediatric deaths linked to flu and RSV this season, urging ...

Moderna, Inc. (NASDAQ:MRNA) today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has granted marketing authorization for mRESVIA (mRNA-1345), indicated for ...